Trident Texofab [TTFL] vs Raymond [RAYMOND] Detailed Stock Comparison

Trident Texofab Ltd.

BSE
Loading...

Raymond Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Trident Texofab Ltd. wins in 8 metrics, Raymond Ltd. wins in 11 metrics, with 0 ties. Raymond Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Trident Texofab Ltd. Raymond Ltd. Better
P/E Ratio (TTM) 28.42 55.24 Trident Texofab Ltd.
Price-to-Book Ratio 1.41 0.89 Raymond Ltd.
Debt-to-Equity Ratio 55.71 29.43 Raymond Ltd.
PEG Ratio 0.95 -0.59 Trident Texofab Ltd.
EV/EBITDA 14.01 18.42 Trident Texofab Ltd.
Profit Margin (TTM) 2.63% 248.57% Raymond Ltd.
Operating Margin (TTM) 4.80% 3.91% Trident Texofab Ltd.
EBITDA Margin (TTM) 4.80% 3.91% Trident Texofab Ltd.
Return on Equity 5.31% 183.56% Raymond Ltd.
Return on Assets (TTM) 2.50% 98.90% Raymond Ltd.
Free Cash Flow (TTM) $-137.22M $752.80M Raymond Ltd.
1-Year Return -78.12% -14.21% Raymond Ltd.
Price-to-Sales Ratio (TTM) 0.67 1.31 Trident Texofab Ltd.
Enterprise Value $1.12B $32.61B Raymond Ltd.
EV/Revenue Ratio 0.91 1.48 Trident Texofab Ltd.
Gross Profit Margin (TTM) 13.88% 42.09% Raymond Ltd.
Revenue per Share (TTM) $89 $331 Raymond Ltd.
Earnings per Share (Diluted) $1.93 $7.86 Raymond Ltd.
Beta (Stock Volatility) -1.07 -0.04 Trident Texofab Ltd.

Trident Texofab Ltd. vs Raymond Ltd. Stock Performance Analysis

Loading Price Chart...

TTFL
RAYMOND

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Trident Texofab Ltd.-1.43%-7.27%-17.33%-40.85%-88.16%-83.35%
Raymond Ltd.-3.19%-3.20%10.73%35.39%10.03%20.99%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Trident Texofab Ltd.-78.12%-29.83%17.27%1.25%1.25%1.25%
Raymond Ltd.-14.21%-65.70%36.29%11.45%51.80%21.23%

Performance & Financial Health Analysis: Trident Texofab Ltd. vs Raymond Ltd.

MetricTTFLRAYMOND
Market Information
Market Cap i₹856.11M₹28.90B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i104,045652,889
90 Day Avg. Volume i100,404527,460
Last Close₹40.07₹514.95
52 Week Range₹38.57 - ₹379.00₹320.00 - ₹783.90
% from 52W High-89.43%-34.31%
All-Time High₹379.00 (Oct 23, 2025)₹3,496.00 (Jul 08, 2024)
% from All-Time High-89.43%-85.27%
Growth Metrics
Quarterly Revenue Growth-0.19%-0.42%
Quarterly Earnings Growth0.90%-0.95%
Financial Health
Profit Margin (TTM) i0.03%2.49%
Operating Margin (TTM) i0.05%0.04%
Return on Equity (TTM) i0.05%1.84%
Debt to Equity (MRQ) i55.7129.43
Cash & Liquidity
Book Value per Share (MRQ)₹38.87₹488.48
Cash per Share (MRQ)₹0.09₹136.87
Operating Cash Flow (TTM) i₹-106,030,000₹69.27B
Levered Free Cash Flow (TTM) i₹25.10M₹76.31B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00₹0.00

Valuation & Enterprise Metrics Analysis: Trident Texofab Ltd. vs Raymond Ltd.

MetricTTFL (Apr 24, 2026)RAYMOND (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i28.4255.24
Forward P/E iN/A23.34
PEG Ratio i0.95-0.59
Price to Sales (TTM) i0.671.31
Price to Book (MRQ) i1.410.89
Market Capitalization
Market Capitalization i₹856.11M₹28.90B
Enterprise Value i₹1.12B₹32.61B
Enterprise Value Metrics
Enterprise to Revenue i0.911.48
Enterprise to EBITDA i14.0118.42
Risk & Other Metrics
Beta i-1.07-0.04
Book Value per Share (MRQ) i₹38.87₹488.48

Financial Statements Comparison: Trident Texofab Ltd. vs Raymond Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTTFL (2025)RAYMOND (2025)
Revenue/Sales i1.22B18.61B
Cost of Goods Sold i1.08B11.87B
COGS % of Revenue i88.2%63.8%
Gross Profit i144.40M6.74B
Gross Margin i11.8%36.2%
Research & Development i4,000N/A
Operating Income (EBIT) i57.23M316.80M
Operating Margin i4.7%1.7%
EBITDA i82.31M2.38B
EBITDA Margin i6.7%12.8%
Pre-Tax Income i25.76M783.40M
Pre-Tax Income % of Revenue i2.1%4.2%
Income Tax i656,000263.20M
Income Tax % of Revenue i0.1%1.4%
Net Income (Profit) i25.10M76.36B
Profit Margin i2.1%410.4%

Balance Sheet & Liquidity Metrics

MetricTTFL (2025)RAYMOND (2025)
Cash & Equivalents i1.09M343.70M
Total Current Assets i737.44M52.03B
Total Current Assets % of Revenue i60.4%279.6%
Total Current Liabilities i407.50M30.16B
Total Current Liabilities % of Revenue i33.4%162.1%
Long-Term Debt i102.71M3.45B
Long-Term Debt % of Revenue i8.4%18.5%
Total Shareholders Equity i472.39M41.58B
Retained Earnings i77.13M18.59B
Retained Earnings % of Revenue i6.3%99.9%
Property, Plant & Equipment i31.11M8.90B

Cash Flow Statement Comparison

MetricTTFL (2025)RAYMOND (2025)
Operating Cash Flow i-106.03M69.27B
Operating Cash Flow % of Revenue i-8.7%372.3%
Capital Expenditures i0-1.42B
Free Cash Flow i-137.22M752.80M
FCF Margin i-11.2%4.0%
Debt Repayment i-104.82M-1.54B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTTFLRAYMOND
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i15.00M66.55M
Float Shares i8.29M31.63M
% Held by Insiders i37.74%51.24%
% Held by Institutions i0.00%8.54%
% Held by Public i62.26%40.22%

Dividend Analysis & Yield Comparison: Trident Texofab Ltd. vs Raymond Ltd.

MetricTTFLRAYMOND
Last 12-Month Dividend i₹0.00₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00₹5.33
3-Year Avg Dividend Yield iN/A0.31%
3-Year Total Dividends i₹0.00₹16.00
Ex-Dividend DateN/AJun 13, 2024